Literature DB >> 17095292

Multifocal motor neuropathy with conduction block: Distribution of demyelination and axonal degeneration.

Steve Vucic1, Kristin Black, Peter Siao Tick Chong, Didier Cros.   

Abstract

OBJECTIVE: Multifocal motor neuropathy with conduction block (MMN) is an immune-mediated neuropathy, characterized by progressive muscle weakness. Although demyelination is regarded as the underlying pathophysiologic mechanism of MMN, recently, it was reported that different pathophysiologic mechanisms were responsible for disease in the upper and lower limbs. Specifically, demyelination in the upper limbs and axonal loss in the lower limbs. Consequently, the aim of the present study was to assess, through clinical neurophysiology studies, whether different pathophysiologic mechanisms were occurring in the upper and lower extremities. Furthermore, we wanted to investigate whether the presence of conduction block (CB) correlated with axonal degeneration (AD), and to determine the electrophysiological abnormalities that correlate with muscle weakness.
METHODS: We reviewed medical records of 18 patients with MMN for clinical features (using the Medical Research Council score and Guys Neurology Disability Scale) and neurophysiologic abnormalities (CB, AD prolongation of distal motor and F-wave latencies, and reduction of conduction velocity in the demyelinating range).
RESULTS: Electrophysiological abnormalities deemed specific of demyelination were non-significantly different in the upper and lower extremities. The presence of axonal degeneration correlated significantly with conduction block (odds ratio 10.4, 95% CI 4.2-25.6), and both parameters correlated with muscle weakness (P<0.01).
CONCLUSION: Our study suggests that the same pathophysiologic process occurs in the upper and lower extremity nerves. Moreover, one pathophysiologic process may be responsible for the development of CB and AD, and therefore muscle weakness. SIGNIFICANCE: The present study has established that both AD and CB occur in MMN, irrespective of extremity, and both correlate with muscle weakness.

Entities:  

Mesh:

Year:  2006        PMID: 17095292     DOI: 10.1016/j.clinph.2006.09.020

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  10 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

Review 2.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

3.  Diagnostic signs of motor neuropathy in MR neurography: nerve lesions and muscle denervation.

Authors:  Daniel Schwarz; Markus Weiler; Mirko Pham; Sabine Heiland; Martin Bendszus; Philipp Bäumer
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

4.  Further insight on A-wave in acute and chronic demyelinating neuropathies.

Authors:  Ferdinando Sartucci; Tommaso Bocci; Davide Borghetti; Giovanni Orlandi; Francesco Manfredonia; Luigi Murri; Fabio Giannini; Alessandro Rossi
Journal:  Neurol Sci       Date:  2010-06-18       Impact factor: 3.307

5.  Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?

Authors:  Emilien Delmont; Charles Benaïm; Mael Launay; Sabrina Sacconi; Marie-Hélène Soriani; Claude Desnuelle
Journal:  J Neurol       Date:  2009-07-30       Impact factor: 4.849

6.  IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up.

Authors:  Andreas Baumann; Christian W Hess; Matthias Sturzenegger
Journal:  J Neurol       Date:  2009-04-09       Impact factor: 4.849

7.  Predicting a positive response to intravenous immunoglobulin in isolated lower motor neuron syndromes.

Authors:  James R Burrell; Con Yiannikas; Dominic Rowe; Matthew C Kiernan
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

Review 8.  Differentiating lower motor neuron syndromes.

Authors:  Nidhi Garg; Susanna B Park; Steve Vucic; Con Yiannikas; Judy Spies; James Howells; William Huynh; José M Matamala; Arun V Krishnan; John D Pollard; David R Cornblath; Mary M Reilly; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-12-21       Impact factor: 10.154

Review 9.  The utility of electrodiagnostic tests for the assessment of medically unexplained weakness and sensory deficit.

Authors:  Josep Valls-Solé
Journal:  Clin Neurophysiol Pract       Date:  2016-04-02

10.  Motor unit integrity in multifocal motor neuropathy: A systematic evaluation with CMAP scans.

Authors:  Diederik J L Stikvoort García; Maria O Kovalchuk; H Stephan Goedee; Leonard J van Schelven; Leonard H van den Berg; Hessel Franssen; Boudewijn T H M Sleutjes
Journal:  Muscle Nerve       Date:  2021-12-16       Impact factor: 3.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.